Member Info for Ivyspivey

Hi Hasiba,
Hope you are well.
What an absolute cracking day.Makes up for previous disappointments elsewhere.
I remember the ride up to 16p here on FDA Approval for Stonechecker abd think of how much moe we can offer now

Morning Draft,
Not a bad day considering here and the other TB Company

https://www.lse.co.uk/rns/SCLP/directors-dealings-817aeparhf1u9sg.html

Sorry 925k

https://www.lse.co.uk/rns/SCLP/directors-dealings-817aeparhf1u9sg.htmlSo is there another 750k to come

Thanks Bermuda,
Crumbs and LL yep it is just such a strange thing and you can see from DE comments that he was not impressed.Am agreed to think it was the 2nd tranche that Vulpes bought at 5.2 that is being sold and not the initial purchase.
They did not sell after the initial one when the SP rise a lot and I am trying to remember the circumstances of the 2nd tranche was it to remove some of CH overhang and if so may not have been done for pure investment reasons just to bail out the SP hence nay always have been fir the short term and Friday presented a nice opportunity.

Stephen Diggle bought 3 separate though fairly small lots in last 2 weeks.
Think DEs take is interesting and he considers it a very bad move whatever the rationale behind it.
Would be nice if anyone does e mail CH etc to get some clarification on the reasoning as given the pharma sentiment on AIM I think without those sells we would be comfortably in double figures.
But no matter

Looed thanks and does make sense and don’t think the Arbitrators would argue that FRR have not tried to actively developed Tarabani.
It is the other 99% which the GG seem to have highlighted and it does seem that FRR have tried to “ claim” it all.
There is a pattern as they seemed happy enough to commit to Ukraine and Moldova but seem to be empty promises which we always believed as they were a front of bigger backers.
Anyway the arbitration is out if the way and whether FRR have anything if value left we wait and see.
The only good thing about being delisted is that we dont have to worry about any more costs incurred as a result of the arbitration decision but of course we may have lost our investment which is of little comfort.

I can’t see any other 1.5m trades so either separate ones at 8p although RNS says it was one transaction or it has not been printed yet OR it was the buy at 8.35

Likewise Achilles the skin in the game by the BoD and likes of Myles means they are truly alogned

Thanks Oopsi
TBH if FRR just sat on the 99% of the field and it appears from the arbitration that the tribunal agreed with that claim then they deserve to lose as they clearly violated the terms of the PSA and should have returned it back in 2017.
There may be other areas where FRR have a claim but this explains the huge uplift in FRR activity about this time to start looking at other areas and plans.
It appears it could get about providing a defence in the arbitration claims rather than a serious attempt to progress matters.
Who knows but hopefully we still have a pulse but ZM really should be up front with what is going on worth SH and the wider world.
It does look very black here but it would be nice to finally know one way or the other

Sorry Crumbs you beat me to it

Of Jonathan Ball Tweet.

Excited at the prospect of helping #LindyDurrant on this together with top virus guys @rich_urbanowic, @Theo_Tsoleridis, #ChrisColeman and @JanetDaly5 with crucial vaccine delivery expertise from @JamesEdDixon #DreamTeam

Do we think it was his wife or brother?

A good listen and hope it comes to fruition.
It reminded me of a launch I was involved in a few years back when a new Cat Vaccine was introduced.Part of its viral vector technology was to stimulate both an Antibody response which the majority of the existing Vaccines did but also to promote the response of T Cells which was new to the market.
The results in terms of efficacy and in particular the potency and duration of immune response were a big improvement on the competitors especially in the case of FeLV( which was always the least responsive of the virus,s.
FeLV=Feline Leukaemia Virus.

I know that is not in humans but the basic immune responses are not too dissimilar.

Morning all,
Inanaco normally the Covid 19 Vax would likely require an adjuvant if killed or irradiated antigenic strains are used due to fear of mutation and the need to reduce reversion to virulence threat.
If you are right about no need for an adjuvant due to sufficient cell mediated and humoral response then that would be a real bonus.
Hope you are right.

Really looking forward to this week ahead.
Hope you all had a good w/end and GLA

Prefer Georgia’s got talent.

https://www.iptv.ge/en/rustavi2-videos/nichieri

Starting with a dramatic expansion of testing from 1 million tests per week to initially 3 million per week and then 30 million per week

https://www.atlanticcouncil.org/event/national-covid19-testing-action-plan/

You can see from this how much the US intends to ramp up testing in the coming months.

Hi Flakey,
Good response from BBF.
The LSE platform is not great but I like Level 2 when shares are moving quickly as they are at the moment.It easily covers the charge imo and I like everything on one platform.
If you are serious trading I would look elsewhere but as I said on fast moving shares you need it to get entry and exit points.